ImmunityBio, Inc. Common Stock (IBRX) News
Latest headlines that mention IBRX, newest first · each headline opens the original publisher
- Last price
- $9.91
- Day change
- +1.64%
- Next earnings
- 2026-11-03
IBRX headlines
latest coverageImmunityBio's stock is moving higher after the FDA announced it would review a possible label expansion for the company's core Anktiva drug.
Also mentioned with IBRX
30dHeadlines that tag both tickers
IBRX news alerts
Get an alert by email or push when a new headline mentions IBRX.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.